Gene Query: MRPL27

Dataset Description Geneva Score
Comprehensive comparative analysis of 5’ end RNA sequencing methods 25.84
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 23.88
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 22.51
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 22.29
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 22.29
Identification of transcription start sites for human A549 cell line using ReCappable-seq 19.64
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 15.99
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 15.47
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 14.62
Expression by CD133+ cells isolated from the adult human exocrine pancreas 14.42
DART-seq: an antibody-free method for global m6A detection 14.28
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.92
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.46
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 12.33
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 12.29
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 12.23
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 12.12
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 12.12
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 11.88
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 11.7
Global analysis of enhancer targets: Mosaic-seq 11.65
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 11.37
ETV7 and interferon response 11.37
The comparison of high-throughput single-cell RNA-seq methods 11.26
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.72
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 10.07
Rorc disruption in human FG pancreatic cancer cells 9.9
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.62
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.58
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 9.53
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 9.44
SLAM-seq for K562 endogenous mRNA decay 9.39
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 9.21
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 8.85
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 8.85
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 8.8
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.75
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 8.7
RNA-seq data 8.65
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.26
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 8.19
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 8.11
Regulatory network controlling tumor-promoting inflammation in human cancers 8.11
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.07
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 8.02
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.98
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.95
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 7.91
Differential gene expression of human melanoma cells [RNA-seq] 7.78
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.78
CROP-Seq in Primary Human T Cells 7.69
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.66
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.66
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 7.62
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 7.59
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 7.54
scRNASeq analysis of cycling cardiomyocytes 7.46
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.43
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.41
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.29
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.19
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 7.11
Silencing p300 in MCF7 cells to study expression and alternative splicing 7.08
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 7.07
Human Treg IL-12 stimulation 7.05
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.96
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.94
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.92
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.91
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.91
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.67
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.66
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.66
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.66
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.63
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.61
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 6.57
Differentially expressed genes post knock down of lincDUSP26 6.55
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.55
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 6.53
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.5
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.5
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.49
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.49
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 6.48
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6.42
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.42
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.42
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.38
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 6.37
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 6.36
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 6.32
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.28
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.28
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 6.26
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 6.23
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 6.23
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.2
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 6.12
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 6.11
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 6.08
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 6.08
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.07
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.05
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.04
Impact of dieldrin on transcription in Jurkat T cells 6.03
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.97
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.92
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.9
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.89
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.87
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 5.86
The evolution of N6-methyladenosine in primates 5.79
H1609088 Human RNA-Sequencing 5.77
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 5.76
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.71
Effect of FGF13 depletion on the H460 cell line 5.6
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.56
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.56
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 5.52
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 5.42
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 5.42
Generation and persistence of human tissue-resident memory T cells in lung transplantation 5.34
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 5.3
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.22
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.2
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.2
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.17
Cajal bodies are linked to genome conformation 5.14
Cajal bodies are linked to genome conformation [RNA-Seq] 5.14
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 5.13
Genome wide expression change in LCC2 and MCF-7 cells 5.1
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.08
Systematic discovery of endogenous human ribonucleoprotein complexes 5.06
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.06
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.02
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 5.01
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 5.01
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 5.0
A Unique Epigenomic Landscape Defines Human Erythropoiesis 5.0
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.95
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 4.94
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.94
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.94
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 4.93
Trans-differentiation of human adult peripheral blood T cells into neurons 4.92
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.91
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.89
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.83
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.83
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 4.83
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 4.76
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 4.69
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.58
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.56
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 4.55
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.52
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.48
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 4.42
Transcriptome sequencing of K-562 cells 4.41
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.39
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.37
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.36
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.34
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 4.32
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.32
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.29
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.28
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.28
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 4.27
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.25
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.25
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.25
Paxillin regulates genomic networks in prostate cancer [PC3] 4.23
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.22
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.21
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.2
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 4.2
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 4.2
Functional role of CPPED1 in trophoblasts. 4.2
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 4.19
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.19
FBXW7 modulates stress response by post-translational modification of HSF1 4.14
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.14
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.1
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.1
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.1
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.1
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.1
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.09
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.08
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 4.08
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.08
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.06
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.05
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.05
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 4.04
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.04
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 4.03
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.02
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 4.01
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.93
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.89
Identification of HOXB13 target genes responsive to BET inhibitors 3.85
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.84
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.83
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.83
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 3.79
hTERT promotes cell adhesion and migration independent of telomerase activity 3.78
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.76
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.72
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.72
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.7
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.7
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 3.7
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.69
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 3.67
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.66
Energy Metabolism during Anchorage-Independence 3.62
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.62
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.61
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.61
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.61
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.6
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 3.6
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.58
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.57
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.57
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.56
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.55
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.53
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.52
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 3.5
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 3.45
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 3.45
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.43
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.43
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.41
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.41
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.41
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.4
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.4
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.39
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.39
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.34
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.31
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.27
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.26
N6-methyladenine DNA Modification in Glioblastoma 3.26
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 3.26
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 3.26
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 3.25
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.23
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.23
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 3.23
RNA-seq analysis and shRNA screen of breast cancer 3.21
RNA-seq analysis of breast cancer 3.21
Ribosome profiling upon inhibition of eIF4A 3.2
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.17
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.17
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  3.17
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 3.17
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.16
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.14
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.12
Seletive inhibition of CDK9 in DLBCL cell lines 3.1
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 3.09
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 3.09
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.09
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.04
Downregulation of DDX5/DDX17 and REST 3.04
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.94
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.94
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.94
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.94
AUF-1 affected genes in human skin cells 2.92
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 2.9
Copper Regulation of HIF-1 Transcription Activity 2.88
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.88
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 2.87
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.87
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.86
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.86
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.85
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 2.81
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.81
RNA editing in nascent RNA affects pre-mRNA splicing 2.8
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.8
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.79
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 2.77
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.75
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.72
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.72
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 2.71
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.7
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.69
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.68
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.65
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.63
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.63
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.63
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.59
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.59
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.59
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.58
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.57
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.52
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.52
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.51
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.5
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.49
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.45
CD73 knockdown effect in pancreatic cancer cell lines 2.44
Functional significance of the HIV-1 Tat signature amino acid residues 2.44
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.43
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.43
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.4
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.37
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.32
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.32
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 2.29
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.27
The transcriptome effect of overexpressing EZH2 in MCF7 2.24
Gene expression profile in breast cancer cell lines using RNA sequencing 2.24
RNA-sequencing of healthy human skeletal myocytes 2.23
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.22
Proliferation-correlated expression 2.21
Gene expression signatures of innate lymphoid cells from human blood 2.21
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.2
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.18
RNA-seq analysis upon ARID1B overexpression 2.17
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.17
Transcriptional landscape changes during human embryonic stem cell derivation 2.15
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.14
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.13
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.13
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.12
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.12
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.12
RNAseq of cell lines with knocked in ESR1 mutations 2.12
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.11
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.08
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.07
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.06
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.05
TT-Seq captures the human transient transcriptome 2.04
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.01
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.01
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.01
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.01
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.98
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.97
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.96
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.96
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.95
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.93
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.93
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.92
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.92
Chromatin landscape of human visceral and subcutaneous adipocytes 1.91
Effect of ILF3 on translation during homeostasis and the antiviral response 1.83
Iron response of HepG2 cells 1.82
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.81
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.81
The cohesin complex prevents Myc-induced replication stress 1.81
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.8
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.8
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.79
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.77
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.77
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.77
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.76
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.76
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.76
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.75
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.74
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.73
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.72
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.71
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.67
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.64
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.61
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.61
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.61
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.6
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.59
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.58
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.55
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.55
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.54
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.53
Illumina Total RNA-seq in HeLa 1.5
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 1.5
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.47
Global transcriptome analysis of HAP1 cells 1.46
miRNAs affected by antagomiR-17 treatment 1.45
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.43
The circadian transcriptional landscape in primary human mammary epithelial cells 1.43
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 1.37
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.29
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.27
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.26
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.26
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.22
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.2
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.2
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.2
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.16
Single-cell analysis of adult human ovary using 10X genomics 1.14
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.11
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.1
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.08
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.08
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 1.06
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.06
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.06
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.06
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.04
MCF-7 as a model for functional analysis of breast cancer risk variants 1.04
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.04
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.01
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.01
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.99
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.97
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.95
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.94
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.94
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.92
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.9
Targeting MTHFD2 in Acute Myeloid Leukemia 0.89
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.89
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.88
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.87
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.83
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.83
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.8
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.79
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.79
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.76
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.76
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.75
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.72
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.71
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.68
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.67
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.61
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.58
RNA seq with AML (NB4) cells upon FTO inhibition 0.57
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.55
Single-cell analysis of human kidney organoids 0.53
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.53
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.53
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.52
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.52
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.5
RNA-Seq of PRMT1 overexpression ECA109 cells 0.5
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.47
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.46
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.44
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.4
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.38
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.37
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.35
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.35
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.34
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.3
RNA seq analysis of human Fetal and adult derived Enterospheres 0.29
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.28
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.21
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.21
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.2
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.19
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.18
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.17
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.17
Function and hormonal regulation of GATA3 in human first trimester placentation 0.16
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.16
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.16
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.15
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.15
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.15
RNA-Seq and expression data from human adipose tissue 0.14
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.14
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.1
Global transcriptome analysis of WT versus HEB-/- hESCs 0.1
NR2F2 study 0.09
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 0.09
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.09
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.09
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.07
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.06
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.03
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.02
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.02
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.01
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.0
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation